Prognostic Factors and Intensive Care Outcome in Post-Transplant Phase of Hematopoietic Stem Cell Transplantation: Intensive Care Outcome in Hematopoietic Stem Cell Transplantation.

critically ill mortality transplantation

Journal

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
ISSN: 0971-4502
Titre abrégé: Indian J Hematol Blood Transfus
Pays: India
ID NLM: 9425818

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 08 06 2022
accepted: 30 08 2022
pmc-release: 01 04 2024
medline: 4 4 2023
entrez: 3 4 2023
pubmed: 4 4 2023
Statut: ppublish

Résumé

To identify new clinical and biologic parameters associated with short-term survival in allogeneic or autologous hematopoietic stem cell transplantation (HSCT) patients who were admitted to the intensive care unit (ICU) during their post-transplant period. 40 patients who were admitted to the ICU in our center during their post-transplant period were evaluated retrospectively between Jan 2014 - Jun 2021. Baseline patient characteristics before the transplant, reasons for ICU admissions, laboratory and clinical findings, supportive treatment in ICU and short-term survival were analyzed. We found 8.8% ICU admission rate in all patient group (n = 450). Mortality rate of the patients who were admitted to ICU was 75%. Invasive mechanic ventilation, need for vasopressor, heart rate was significantly different between survivor and non-survivor group (p = 0.001, p = 0.001, p = 0.004). Elevated INR was associated with poor survival on ICU (p = 0.033). APACHE II score was an independent predictor of ICU mortality (p = 0.045). Despite the recent advances in transplant conditioning protocols, prophylaxis strategies and improvements of management in ICU, overall survival for HSCT patients in ICU is still poor. In this study INR level was described as a new prognostic factor in ICU for first time in the literature.

Identifiants

pubmed: 37006979
doi: 10.1007/s12288-022-01575-5
pii: 1575
pmc: PMC10064358
doi:

Types de publication

Journal Article

Langues

eng

Pagination

167-172

Informations de copyright

© The Author(s), under exclusive licence to Indian Society of Hematology and Blood Transfusion 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Déclaration de conflit d'intérêts

Conflict of interestAll authors declare no conflict of interest that may have influences either the conduct or the presentation of the research.

Références

Chest. 2004 Nov;126(5):1604-11
pubmed: 15539734
Intern Med J. 2012 Jul;42(7):748-54
pubmed: 21627739
Sci Rep. 2019 Dec 27;9(1):19911
pubmed: 31882648
Bone Marrow Transplant. 2009 Mar;43(5):411-5
pubmed: 18936734
Bone Marrow Transplant. 2018 Oct;53(10):1233-1241
pubmed: 29703972
Int J Hematol. 2018 Dec;108(6):622-629
pubmed: 30238198
Bone Marrow Transplant. 2019 Mar;54(3):418-424
pubmed: 30082850
BMC Pediatr. 2016 Aug 20;16(1):138
pubmed: 27544347
Biol Blood Marrow Transplant. 2009 Jan;15(1 Suppl):149-53
pubmed: 19147097
Bone Marrow Transplant. 2011 Sep;46(9):1186-91
pubmed: 21042315
Neth J Med. 2014 Feb;72(2):107-12
pubmed: 24659598
Br J Haematol. 2013 May;161(4):578-86
pubmed: 23496350
Mayo Clin Proc. 1992 Feb;67(2):117-22
pubmed: 1545573
J Clin Oncol. 2006 Feb 1;24(4):643-9
pubmed: 16380411
Ann Hematol. 2008 Apr;87(4):299-304
pubmed: 18219487
Blood. 2004 Sep 1;104(5):1550-8
pubmed: 15150081
Bone Marrow Transplant. 1998 Apr;21(7):697-704
pubmed: 9578310

Auteurs

Yaşa Gül Mutlu (YG)

Department of Hematology, Istanbul Medipol University, Istanbul, Turkey.

Berrin Balik Aydin (BB)

Department of Hematology, Istanbul Medipol University, Istanbul, Turkey.

Cem Erdogan (C)

Department of Anesthesiology, Istanbul Medipol University, Istanbul, Turkey.

Deniz Kizilaslan (D)

Department of Anesthesiology, Istanbul Medipol University, Istanbul, Turkey.

Hüseyin Saffet Beköz (HS)

Department of Hematology, Istanbul Medipol University, Istanbul, Turkey.

Aliihsan Gemici (A)

Department of Hematology, Istanbul Medipol University, Istanbul, Turkey.

Leylagül Kaynar (L)

Department of Hematology, Istanbul Medipol University, Istanbul, Turkey.

Ömür Gökmen Sevindik (ÖG)

Department of Hematology, Istanbul Medipol University, Istanbul, Turkey.

Classifications MeSH